Eitan Friedman
#165,790
Most Influential Person Now
Researcher
Eitan Friedman's AcademicInfluence.com Rankings
Eitan Friedmanphilosophy Degrees
Philosophy
#9752
World Rank
#13356
Historical Rank
Logic
#6712
World Rank
#8257
Historical Rank
Eitan Friedmanbiology Degrees
Biology
#13431
World Rank
#16976
Historical Rank
Computational Biology
#313
World Rank
#314
Historical Rank
Genetics
#1500
World Rank
#1602
Historical Rank
Molecular Biology
#2274
World Rank
#2308
Historical Rank
Download Badge
Philosophy Biology
Eitan Friedman's Degrees
- PhD Genetics Tel Aviv University
- Masters Biology Tel Aviv University
- Bachelors Life Sciences Tel Aviv University
Similar Degrees You Can Earn
Why Is Eitan Friedman Influential?
(Suggest an Edit or Addition)Eitan Friedman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. (1991) (1502)
- Salpingo-Oophorectomy and the Risk Of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation (2006) (566)
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
- Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. (2005) (456)
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
- Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. (2015) (390)
- Somatic mutations in the neurofibromatosis 1 gene in human tumors (1992) (389)
- Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. (2002) (369)
- A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population (2010) (357)
- Cancer risks among BRCA1 and BRCA2 mutation carriers (2007) (336)
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers (2008) (336)
- Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. (2006) (322)
- Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer. (2008) (322)
- Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) (1996) (318)
- Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. (1989) (314)
- Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers (2014) (314)
- An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge (2014) (306)
- Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33 (2008) (304)
- Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2 (2014) (288)
- RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. (2007) (276)
- Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update (2006) (270)
- Genome-wide association study identifies three new melanoma susceptibility loci (2011) (252)
- Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia: Clinical Features and Assignment of the Disease Gene to Chromosome 1p13-21 (2001) (248)
- Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. (1990) (246)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
- Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. (2007) (243)
- Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. (2008) (238)
- The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers (2012) (223)
- Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study (2014) (222)
- Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. (2004) (218)
- Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. (2006) (217)
- Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. (2002) (217)
- Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. (2010) (212)
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers (2017) (211)
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (2018) (206)
- Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma (2015) (199)
- Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (2010) (196)
- Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers (2008) (190)
- No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. (1994) (187)
- Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers (2005) (183)
- Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. (2008) (182)
- Second international consensus guidelines for breast cancer in young women (BCY2). (2014) (179)
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer (2014) (176)
- Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer (2011) (174)
- Genotype–phenotype correlations in Peutz-Jeghers syndrome (2004) (174)
- Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (154)
- The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. (1998) (149)
- Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. (1993) (144)
- The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. (2007) (138)
- Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. (2007) (134)
- The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. (2002) (129)
- Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers (2019) (129)
- Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. (2009) (124)
- Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high‐risk women (2010) (123)
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
- A variant in FTO shows association with melanoma risk not due to BMI (2013) (120)
- Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk (2013) (120)
- Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. (2000) (119)
- Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors. (1993) (113)
- DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (112)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
- Allelic loss from chromosome 11 in parathyroid tumors. (1992) (107)
- Local microRNA delivery targets Palladin and prevents metastatic breast cancer (2016) (106)
- Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study (2011) (104)
- Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. (1991) (104)
- The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length (2014) (103)
- Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors. (1994) (97)
- Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. (2006) (96)
- The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group. (2000) (96)
- The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms. (1993) (96)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
- Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2005) (93)
- Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. (1996) (92)
- Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility (2020) (87)
- Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations. (2007) (86)
- The R72P P53 mutation is associated with familial breast cancer in Jewish women (2005) (84)
- Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. (2011) (82)
- Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study. (2017) (80)
- Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers (2006) (80)
- Genotyping of Patients with Sporadic and Radiation-Associated Meningiomas (2005) (78)
- Genetic abnormalities in sporadic parathyroid adenomas. (1990) (78)
- BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles. (2015) (76)
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
- Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. (2015) (75)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
- Haplotype structure and selection of the MDM2 oncogene in humans (2007) (74)
- Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients. (2017) (74)
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (2017) (70)
- Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. (2005) (68)
- Lessons learned — resolving the enigma of genetic factors in IBS (2016) (67)
- Shared heritability and functional enrichment across six solid cancers (2018) (67)
- Nonsense mutations in the C–terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours (1993) (66)
- Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel. (2003) (66)
- The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel (2001) (65)
- Comparative genomic hybridization analysis of nonfunctioning pituitary tumors. (1998) (63)
- The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel (2000) (62)
- Genome-wide association study identifies a novel variant in RAD51B associated with male breast cancer risk (2012) (61)
- Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants (2020) (60)
- Screening for mutations in candidate genes for hypospadias (1999) (59)
- Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (58)
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
- Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson’s Disease (2014) (58)
- Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes. (1998) (57)
- The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers (2012) (57)
- High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian Cancer. (1996) (56)
- Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel‐Lindau and RET genes (1997) (56)
- The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing (2011) (56)
- Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors. (1998) (55)
- Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade (2008) (55)
- Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin (2010) (55)
- Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers (2006) (54)
- The phospholipase C beta 3 gene located in the MEN1 region shows loss of expression in endocrine tumours. (1994) (54)
- CHEK2*1100delC and male breast cancer risk in Israel (2004) (53)
- Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2010) (53)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
- Genotype phenotype correlations in Israeli colorectal cancer patients (2005) (52)
- Linkage Analysis of Fifty-Seven Microsatellite Loci to Bipolar Disorder (1993) (51)
- Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non‐Ashkenazi Jewish women with familial breast and ovarian cancer (2000) (51)
- In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. (2005) (50)
- MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish–Ashkenazi descent (2008) (50)
- Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2007) (50)
- Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. (2021) (48)
- Oral Contraceptives and the Risk of Breast Cancer in BRCA 1 and BRCA 2 Mutation Carriers (2002) (47)
- Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers. (2015) (47)
- Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations (2012) (47)
- Studies in a kindred with parathyroid carcinoma. (1992) (47)
- Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women (2002) (46)
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. (2018) (45)
- MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. (2000) (45)
- The Effects of Tadalafil on Cold‐induced Vasoconstriction in Patients with Raynaud's Phenomenon (2007) (45)
- North African Jewish and non-Jewish populations form distinctive, orthogonal clusters (2012) (45)
- Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers (2016) (43)
- Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. (2008) (43)
- Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. (2011) (42)
- CYP2A6 genetic variation and dexmedetomidine disposition (2012) (42)
- Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype (2002) (42)
- Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). (2020) (40)
- BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma (2010) (39)
- Hormone Therapy and the Risk of Breast Cancer in BRCA 1 Mutation Carriers (2008) (39)
- Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel. (2000) (39)
- Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (39)
- Ethnic and Genetic Determinants of Cardiovascular Response to the Selective &agr;2-Adrenoceptor Agonist Dexmedetomidine (2008) (38)
- Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers (2015) (37)
- Genetic analyses of male breast cancer in Israel. (2000) (37)
- Could the 185 deIAG BRCA1 Mutation Be an Ancient Jewish Mutation? (1997) (37)
- Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers (2009) (37)
- Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping (2008) (36)
- Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families (2012) (35)
- ATM haplotypes and breast cancer risk in Jewish high-risk women (2006) (34)
- International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation (2011) (34)
- Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel. (2002) (33)
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease. (2015) (33)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
- Sporadic cardiac myxomas and tumors from patients with Carney complex are not associated with activating mutations of the Gsα gene (1996) (32)
- Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers (2013) (32)
- Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions (2014) (32)
- The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation (2009) (31)
- Inter- and intra-lesional molecular heterogeneity of oral leukoplakia. (2015) (31)
- COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases (2021) (31)
- Activating mutations of the G[sub s] [alpha]-gene in nonfucntioning pituitary tumors (1993) (31)
- Genomic analyses of primary and metastatic serous epithelial ovarian cancer. (2004) (30)
- The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect. (2001) (29)
- The Tyr978X BRCA1 Mutation in Non-Ashkenazi Jews: Occurrence in High-Risk Families, General Population and Unselected Ovarian Cancer Patients (2001) (29)
- The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers. (2016) (29)
- Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (29)
- Mutations of the Gs a-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis (29)
- Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsα and Gi2α genes (2001) (29)
- Effects of variation in the human α2A‐ and α2C‐adrenoceptor genes on cognitive tasks and pain perception (2010) (29)
- Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families (2000) (29)
- Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. (2002) (28)
- Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) (2009) (28)
- Cutaneous malignant melanoma and Parkinson disease: Common pathways? (2016) (28)
- An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers (2016) (28)
- The contribution of FTO and UCP-1 SNPs to extreme obesity, diabetes and cardiovascular risk in Brazilian individuals (2012) (28)
- Genetic analysis of familial colorectal cancer in Israeli Arabs (2003) (28)
- The polymorphic CAG repeat in the androgen receptor gene in Jewish Israeli women with endometrial carcinoma (2001) (28)
- A homozygous cathepsin C mutation associated with Haim–Munk syndrome (2005) (27)
- Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma (2016) (27)
- Vitamin D and calcium-sensing receptor genotypes in men and premenopausal women with low bone mineral density. (2002) (27)
- Offspring gender ratio and the rate of recurrent spontaneous miscarriages in jewish women at high risk for breast/ovarian cancer. (2004) (27)
- Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: Effects of oral contraceptive use and parental origin of mutation (2011) (27)
- Being ‘at-risk’ for developing cancer: cognitive representations and psychological outcomes (2009) (27)
- The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study (2016) (26)
- Comparative genomic hybridization analysis of craniopharyngiomas. (2003) (26)
- Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study (2015) (26)
- Familial vs sporadic ovarian tumors: characteristic genomic alterations analyzed by CGH. (2003) (26)
- The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients (2001) (26)
- Detection of Pancreatic Carcinoma (Diagnostic Value of K-ras Mutations in Circulating DNA from Serum) (1999) (26)
- Low-level constitutional mosaicism of a de novoBRCA1 gene mutation (2015) (26)
- Anti-Mesothelin Antibodies and Circulating Mesothelin Relate to the Clinical State in Ovarian Cancer Patients (2008) (26)
- Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection* (2019) (26)
- Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients (2004) (25)
- An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (25)
- A novel mutation of presenilin 1 in familial Alzheimer’s disease in Israel detected by denaturing gradient gel electrophoresis (1996) (25)
- High-Level Expression of Receptor Tyrosine Kinase Ret and Responsiveness to Ret-Activating Ligands in Pheochromocytoma Cell Lines from Neurofibromatosis Knockout Mice (2002) (25)
- Nephrogenic diabetes insipidus: an X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal. (1994) (25)
- Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations (2016) (25)
- The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries (2019) (25)
- Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel (2011) (24)
- Genetic Variations in the &agr;2A-Adrenoreceptor Are Associated With Blood Pressure Response to the Agonist Dexmedetomidine (2011) (24)
- Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients (2003) (24)
- Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. (2012) (24)
- A follow‐up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processes (2011) (23)
- Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study (2014) (23)
- Constitutional and somatic mutations in the WTI gene in wilms' tumor patients (1995) (23)
- Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers (2018) (23)
- Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers (2000) (23)
- Genetic variants in the &agr;2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses (2008) (23)
- A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers (2012) (22)
- Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 (2016) (22)
- Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer. (2000) (22)
- Exploring the link between MORF4L1 and risk of breast cancer (2011) (21)
- Localization and identification of the multiple endocrine neoplasia type 1 disease gene. (1994) (21)
- CLINICAL ENDOCRINOLOGY & METABOLISM (1992) (21)
- Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene. (1993) (21)
- GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans. (2009) (21)
- A signal peptide mutation of the arginine vasopressin gene in monozygotic twins (2003) (21)
- The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. (2000) (21)
- Motor progression of Parkinson's disease with the leucine‐rich repeat kinase 2 G2019S mutation (2014) (20)
- Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel (2012) (20)
- Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status. (2000) (20)
- Ubiquitous expression of a cloned murine thymopoietin cDNA. (1997) (20)
- Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 (2016) (20)
- Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer (2001) (20)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
- Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases (2001) (20)
- WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin (1994) (19)
- Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients (2017) (19)
- Germline mutations in the PTEN gene in Israeli patients with Bannayan–Riley–Ruvalcaba syndrome and women with familial breast cancer (2002) (19)
- Genetic analysis of Brugada syndrome in Israel: two novel mutations and possible genetic heterogeneity. (2001) (19)
- Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers (2011) (19)
- Molecular analyses of the vasopressin type 2 receptor and aquaporin‐2 genes in Brazilian kindreds with nephrogenic diabetes insipidus (1999) (19)
- The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients. (2010) (19)
- The In Vitro and In Vivo Antiangiogenic Effects of Flavokawain B (2017) (18)
- Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls (2019) (18)
- Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer. (2007) (18)
- Rates of risk‐reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers (2014) (18)
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
- Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer patients. (2014) (18)
- Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel (2012) (18)
- Comparative genomic hybridization analysis of radiation-associated and sporadic meningiomas. (2001) (18)
- Analysis of microsatellite repeats in pediatric brain tumors. (1995) (18)
- Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (17)
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (2018) (17)
- Effect of the α2C-adrenoreceptor deletion322–325 variant on sympathetic activity and cardiovascular measures in healthy subjects (2007) (17)
- Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models. (2013) (17)
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (2018) (17)
- Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews (1999) (17)
- Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. (2002) (17)
- Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
- Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma. (2009) (16)
- Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers (2015) (16)
- Genotyping of Israeli infertile men with idiopathic oligozoospermia (2002) (16)
- Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancer. (2003) (16)
- Does pathologic complete response predict for outcome in BRCA mutation carriers with triple-negative breast cancer? (2014) (16)
- Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise (2012) (16)
- The role of ras GTPase activating protein in human tumorigenesis. (1995) (16)
- Analysis of BRCA1/BRCA2 genes’ contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women (2008) (16)
- Recapitulating the clinical scenario of BRCA‐associated pancreatic cancer in pre‐clinical models (2018) (16)
- Origin and distribution of the BRCA2-8765delAG mutation in breast cancer (2007) (15)
- A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
- The Genetics of Bene Israel from India Reveals Both Substantial Jewish and Indian Ancestry (2015) (15)
- Prenatal diagnosis of a novel COL1A1 mutation in osteogenesis imperfecta type I carried through full term pregnancy (2000) (15)
- MC1R variant alleles and malignant melanoma risk in Israel. (2009) (15)
- Haplotype of the C61G BRCA1 mutation in Polish and Jewish individuals. (2009) (15)
- Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel (2015) (15)
- The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil. (2016) (15)
- Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (2019) (15)
- The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations (2018) (15)
- GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancer. (2015) (15)
- Odontogenic myxomas are not associated with activating mutations of the Gs alpha gene. (1998) (15)
- Genetic Analyses in Consecutive Israeli Jewish Colorectal Cancer Patients (2005) (15)
- Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes. (2001) (14)
- Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours (2005) (14)
- Germline mutations in RAD51C in Jewish high cancer risk families (2012) (14)
- Evidence for a link between TNFRSF11A and risk of breast cancer (2011) (14)
- The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil. (2016) (14)
- Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers. (2006) (14)
- Radiation Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer. (2020) (14)
- Common Genetic Variants and Modification of Penetrance of BRCA 2-Associated Breast Cancer (2010) (14)
- Monoclonal origin of anatomically distinct basal cell carcinomas. (2006) (14)
- Genotyping of geographically diverse Druze trios reveals substructure and a recent bottleneck (2014) (14)
- Germline mutational analysis of presenilin 1 and APP genes in Jewish-Israeli individuals with familial or early-onset Alzheimer disease using denaturing gradient gel electrophoresis (DGGE) (1998) (13)
- Cell phone use is associated with an inflammatory cytokine profile of parotid gland saliva. (2016) (13)
- Germline Mutations in Familial Papillary Thyroid Cancer (2020) (13)
- Somatic mutation analysis of the APP and Presenilin 1 and 2 genes in Alzheimer's disease brains. (1998) (13)
- Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients. (2006) (13)
- The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer. (2000) (12)
- The Melanocortin 1 Receptor (Mc1r) Variants Do Not Account for the Co-occurrence of Parkinson's Disease and Malignant Melanoma (2014) (12)
- Novel candidate genes putatively involved in stress fracture predisposition detected by whole-exome sequencing. (2014) (12)
- Missense mutation in the MEN1 gene discovered through whole exome sequencing co-segregates with familial hyperparathyroidism. (2013) (12)
- Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. (2016) (12)
- Single‐nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish‐Ashkenazi descent (2010) (12)
- Locoregional treatments and ipsilateral breast cancer recurrence rates in BRCA1/2 mutation carriers. (2020) (11)
- p53 and WAF1 polymorphisms in Jewish‐Israeli women with epithelial ovarian cancer and its association with BRCA mutations (2000) (11)
- Exclusion of the phosphoinositide-specific phospholipase Cβ3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1 (1996) (11)
- Next generation sequencing for newborn screening: are we there yet? (2015) (11)
- Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis (2016) (11)
- Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel (2017) (11)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
- Genetics in melanoma. (2004) (11)
- Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers (2018) (11)
- The 471delAAAG Mutation and C353T Polymorphism in the RNASEL Gene in Sporadic and Inherited Cancer in Israel (2006) (11)
- Candidate genes for multiple endocrine neoplasia type 1 (1995) (10)
- The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers (2012) (10)
- Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like Families (2005) (10)
- The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant (2021) (10)
- The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel (2018) (10)
- Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: Possible role in risk modification for cancer development (2005) (10)
- Long-term remission of disseminated parathyroid cancer following immunotherapy (2019) (10)
- The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer (2012) (10)
- The 1100delAT BRCA1 and the 8765delAG BRCA2 Mutations: Occurrence in High-Risk Non-Ashkenazi Jews and Haplotype Comparison of Jewish and Non-Jewish Carriers (2004) (10)
- No founder effect detected in Jewish Ashkenazi patients with fragile-X syndrome (1997) (9)
- Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer (2014) (9)
- Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection. (2019) (9)
- Microsatellite instability in sporadic parathyroid adenoma. (2000) (9)
- The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in Jewish Ashkenazi women (2009) (9)
- The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews. (2006) (9)
- Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates (2017) (9)
- Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
- A polymorphism in the coding region of the vasopressin type 2 receptor (AVPR2) gene. (1993) (9)
- Ophira M. GinsburgCharmaine Kim-SingWilliam D. Foulkes • Parviz GhadirianHenry T. LynchPing SunSteven A. Narod • Hereditary Breast Cancer Clinical Study Group (2010) (9)
- Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2016) (9)
- The genetic history of Cochin Jews from India (2016) (9)
- Common Susceptibility Loci for Male Breast Cancer (2020) (9)
- MEN 1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1 (2000) (9)
- Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention (2016) (9)
- The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews (2004) (9)
- Exploring the link between MORF4L1 and risk of breast cancer (2011) (8)
- Whole-exome sequencing in individuals with multiple cardiovascular risk factors and normal coronary arteries (2016) (8)
- Performing and Declining PGD: Accounts of Jewish Israeli Women Who Carry a BRCA1/2 Mutation or Partners of Male Mutation Carriers (2017) (8)
- Randomized controlled trial of Inquiry‐Based Stress Reduction (IBSR) technique for BRCA1/2 mutation carriers (2015) (8)
- Expression of rasGTPase activating protein in basal cell carcinoma of the skin. (1998) (8)
- Familial mycosis fungoides: model of genetic susceptibility. (2010) (8)
- Abstracts from the 10th C1-inhibitor deficiency workshop (2017) (8)
- Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers. (2017) (8)
- An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews. (1998) (7)
- The spectrum of tumors harboring BAP1 gene alterations. (2021) (7)
- Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015. (2018) (7)
- Genetic analysis of the catalytic domain of the GAP gene in human lung cancer cell lines (2004) (7)
- Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough? (2019) (7)
- Immunohistochemical analysis of rasGTPase activating protein (rasGAP) in prostate cancer. (1998) (7)
- Adrenal tumors in BRCA1/BRCA2 mutation carriers. (2001) (7)
- Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations (2009) (7)
- Kufor-Rakeb Syndrome/PARK9: One Novel and One Possible Recurring Ashkenazi ATP13A2 Mutation. (2018) (7)
- A missense mutation in Col1A1 in a Jewish Israeli patient with mild osteogenesis imperfecta, detected by DGGE (1997) (7)
- Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers. (2021) (7)
- Activating genomic alterations in the Gs alpha gene (GNAS) in 274 694 tumors (2020) (7)
- Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 Variant. (2016) (7)
- BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters? (2015) (7)
- Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer (2004) (7)
- Mutational analysis of candidate genes in Israeli male breast cancer cases (2018) (6)
- Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in Israel. (2000) (6)
- Phenocopy breast cancer rates in Israeli BRCA1BRCA2 mutation carrier families: is the risk increased in non-carriers? (2012) (6)
- Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review (2020) (6)
- Whole-exome identifies RXRG and TH germline variants in familial isolated prolactinoma. (2016) (6)
- Primary Peritoneal Serous Carcinoma in Men: A Rare and Non-BRCA-associated Entity. (2017) (6)
- SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women (2008) (6)
- Genetic analyses of non-small cell lung cancer in Jewish Israeli patients. (2006) (6)
- Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers (2020) (6)
- Actionable clinical decisions based on comprehensive genomic evaluation in asymptomatic adults (2015) (6)
- Risk‐reducing salpingo‐oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2‐mutation carriers—an Israeli matched‐pair study (2021) (5)
- DNA Base-Excision Repair Genes OGG1 and NTH1 in Brazilian Lung Cancer Patients (2015) (5)
- Mutational Analyses of Candidate Genes in Human Squamous Cell Carcinomas (1999) (5)
- The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients (2019) (5)
- A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women. (2006) (5)
- Inquiry-based stress reduction (IBSR) meditation technique for BRCA1/2 mutation carriers—A qualitative study (2016) (5)
- Mutational analysis of the hMSH6 gene in familial and early-onset colorectal and endometrial cancer in Israeli patients. (2002) (5)
- Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants (2020) (5)
- Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (5)
- Differential analysis of mutations in the Jewish population and their implications for diseases (2017) (5)
- Mutation analysis of the MEN1 gene in Israeli patients with MEN1 and familial isolated hyperprolactinemia. (2000) (5)
- The I1307K APC mutation in a high‐risk clinic setting: a follow‐up study (2005) (5)
- A novel MSH2 germline mutation in a Druze HNPCC family (2007) (4)
- Impact of Ethnicity on Somatic Mutation Rates of Pancreatic Adenocarcinoma (2018) (4)
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
- Immunohistochemical Analyses of Colon Cancer in I1307K APC Mutation Carriers Compared with Noncarriers (2003) (4)
- The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients (2007) (4)
- The Co-occurrence of Breast Cancer and Soft Tissue Sarcoma in a Single Cohort Series (2009) (4)
- Molecular and immunohistochemical analyses of uveal melanoma patient cohort (2019) (4)
- Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms (2019) (4)
- FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patterns. (2014) (4)
- Chemosensitivity and clinical characteristics of pancreatic malignancies in BRCA mutation carriers. (2013) (4)
- Clinical utility of single molecule counting technology for quantification of KIM-1 in patients with heart failure and chronic kidney disease. (2017) (4)
- BRCA1 185delAG mutation in a non-Ashkenazi Jewish woman with early-onset breast and ovarian cancer. (1997) (4)
- A comparative study of different methods for automatic identification of clopidogrel-induced bleedings in electronic health records (2017) (3)
- The α2C-adrenoceptor deletion322–325 variant and cold-induced vasoconstriction (2009) (3)
- Parkinson's Disease Genes Do Not Segregate with Breast Cancer Genes' Loci (2013) (3)
- Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers (2021) (3)
- Are VNTRs co-localizing with breast cancer-associated SNPs? (2018) (3)
- Lack of the predominant BRCA1 and BRCA2 mutations in Jewish ovarian carcinoma patients who previously underwent ovulation induction. (1999) (3)
- Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility (2020) (3)
- The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers (2011) (3)
- Familial Isolated Primary Hyperparathyroidism in a Large Georgian-Jewish Kindred: Genetic Studies (2001) (3)
- Re‐evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant (2021) (3)
- Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study. (2020) (3)
- Germline variant in REXO2 is a novel candidate gene in familial pheochromocytoma (2020) (3)
- Abnormal Findings Detected by Multi‐modality Breast Imaging and Biopsy Results in a High‐risk Clinic (2017) (3)
- A novel polymorphism in the coding region of the vasopressin type 2 receptor gene. (1997) (2)
- p53 and WAFl polymorphisms with epithelial ovarian cancer in Jewish-Israeli women and its association with BRCA mutations (2000) (2)
- 55 Somatic mutational analyses of the APP and Presenillin 1 genes in Alzheimer's disease patients brains using Denaturing Gradient Gel Electrophoresis (DGGE) (1996) (2)
- Pregnancy Associated Breast Cancer Among Israeli BRCA1/BRCA2 Carriers in a High-Risk Clinic. (2022) (2)
- Menopausal hormone therapy for BRCA-mutation carriers: attitudes of Israeli healthcare providers before and after a brief educational intervention. (2019) (2)
- Malignant phenotype and two SDHD mutations in a family with paraganglioma syndrome type 1. (2015) (2)
- Genetic association of the PERIOD3 (PER3) Clock gene with extreme obesity. (2021) (2)
- De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer (2019) (2)
- De novo mutation in MEN1 is not associated with parental somatic mosaicism. (2017) (2)
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (2018) (2)
- The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients (2018) (2)
- Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (2019) (2)
- Effect of Inquiry-Based Stress Reduction on Well-being and Views on Risk-Reducing Surgery Among Women With BRCA Variants in Israel (2021) (2)
- Genetic Analysis of Brazilian Patients with Gallbladder Cancer (2019) (2)
- An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge (2014) (2)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (1)
- Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene (2000) (1)
- Optical Genome and Epigenome Mapping of Clear Cell Renal Cell Carcinoma (2022) (1)
- Proteomic signature for detection of high‐grade ovarian cancer in germline BRCA mutation carriers (2022) (1)
- Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population (2021) (1)
- Colonic adenomas do not cosegregate with the I1307K APC missense mutation in an Israeli non-Ashkenazi family. (2005) (1)
- Syddansk Universitet Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12 p 11 locus (2016) (1)
- Markedly Elevated Galectin-3 Levels in Cardiac Amyloidosis May Indicate Significant Fibrosis (2013) (1)
- The m2 and m4 polymorphisms in CYP1A1 by NcoI digest—Revision of detection method (2000) (1)
- Co-occurrence of MEN1 p.Gly111fs and AIP p.Arg16His Variants in Familial MEN1 Phenotype (2018) (1)
- Ashkenazi Jewish and Other White APC I1307K Carriers Are at Higher Risk for Multiple Cancers (2022) (1)
- Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in $\small \textit{BRCA1}$ and $\small \textit{BRCA2}$ Mutation Carriers (2016) (1)
- Post‐mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high‐risk breast cancer patients (2021) (1)
- Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel (2018) (1)
- Mutational Analysis of the Estrogen Receptor Alpha Gene in Israeli Osteoporotic Men and Women (2001) (1)
- Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant (2021) (1)
- Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (1)
- A germline mutation in the Von Hippel‐Lindau disease gene (L178Q) detected by denaturing gradient gel electrophoresis in a large Jewish‐Yemenite family (1999) (1)
- Abstract OT2-09-01: Pilot study of denosumab inBRCA1/2mutation carriers scheduling for risk-reducing salpingo-oophorectomy (2019) (1)
- A familial syndromic association between cutaneous malignant melanoma and neural system tumours (2004) (1)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
- Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers (2022) (1)
- Germline CHEK 2 Mutations in Jewish Ashkenazi Women at High Risk for Breast Cancer (1)
- Mutation analysis of the MEN1 gene in Israeli patients with MEN1 and familial isolated hyperprolactinemia (2000) (1)
- Hypertrophic cardiomyopathy: failure to demonstrate mutations in exon 13 of the cardiac β myosin heavy-chain gene (1992) (1)
- THE PREVALENCE OF THE MAJOR "JEWISH MUTATIONS" BRCA1 AND BRCA2 IN PROSTATE CANCER PATIENTS IN ISRAEL (1999) (1)
- Cutaneous squamous cell carcinoma and the PARK2 gene (2017) (1)
- Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications (2021) (1)
- Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations (2021) (1)
- Genetic Variations in the . 2A-adrenoreceptor Are Associated with Blood (2017) (1)
- Elevated Plasma Interleukin-6, Endothelin-1, and Matrix Metalloproteinase-9 in Heart Failure Patients are Associated With the Need for Advanced Therapies and Mortality (2015) (1)
- Young women with epithelial ovarian cancer: Prevalence of BRCA mutations and clinical correlates (2016) (1)
- Variable Number Tandem Repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG (2022) (1)
- Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
- Automated Breast Volumetric Sonography Compared with Magnetic Resonance Imaging in Jewish BRCA 1/2 Mutation Carriers. (2016) (0)
- Genetic ancestry, CDKN2A, TP 53, PIK3A, KRAS and BRAF mutations in brazilian patients with gallbladder cancer (2016) (0)
- The genetic history of Cochin Jews from India (2016) (0)
- Superior pathological complete response to neo-adjuvant chemotherapy in breast cancer amongst women with BRCA1/2 mutations. (2009) (0)
- Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants (2022) (0)
- Does the 11307K APC germline mutation change the sequence of colorectal carcinogenesis (1999) (0)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
- Defining intracellular signaling targets in soft tissue sarcoma (STS) using immunohistochemical staining (IHC). (2006) (0)
- The Melanocortin 1 Receptor (Mc1r) Variants Do Not Account for the Co-occurrence of Parkinson's Disease and Malignant Melanoma (2014) (0)
- University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch, (2013) (0)
- The prevalence of the three common Jewish Ashkenazi BRCA1/2 mutations in colorectal patients is not increased (2000) (0)
- Abstract P2-09-16: Clinicopatological features and outcome of breast cancer in CHEK2 germline mutation carriers (2022) (0)
- Comprehensive Genetic Analysis of Druze Provides Insights into Carrier Screening (2023) (0)
- Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis (2022) (0)
- Abstract B06: Proteomic biomarker for detection of ovarian cancer using gynecologic liquid biopsy (2020) (0)
- Colonic Adenomas Do Not Cosegregate with the I1307K APC Missense Mutation in an Israeli Non-Ashkenazi Family (2005) (0)
- The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT (2021) (0)
- Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families (2012) (0)
- Supplementary Material for: BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters? (2016) (0)
- Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers (2022) (0)
- OR15 PGD decisions among young Israeli BRCA1/2 mutation carriers (2014) (0)
- Automated breast volume scanner (ABVS) compared to MRI in BRCA mutation gene carriers (2015) (0)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
- S0016672320000038jra 1..5 (2020) (0)
- The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer (2012) (0)
- Nephrogenic diabetes insipidus : An X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal ( antidluretic hormone ) (0)
- CYP2A6 genetic variation and dexmedetomidine disposition (2012) (0)
- Parathyroid tumors in familial multiple endocrine neoplasia type 1: The role of direct acting oncogenes and tumor suppressor genes (1990) (0)
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (vol 118, pg 266, 2018) (2018) (0)
- Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson’s Disease (2014) (0)
- Genetic testing for assessment of lynch syndrome in young patients with polyps. (2021) (0)
- Erratum: Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients (2004) (0)
- Somatic Mutation Analysis of the MEN1 Gene in Adrenocortical Tumors Using Denaturing Gradient Gel Electrophoresis (DGGE) (2001) (0)
- Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers (2022) (0)
- Genome sequencing of multiple primary tumors to reveal underlying germline cancer susceptibility. (2013) (0)
- Traboulsi syndrome without features of Marfan syndrome caused by a novel homozygous ASPH variant associated with a heterozygous FBN1 variant. (2023) (0)
- Abstract P4-12-09: Low-level constitutional mosaicism of ade novo BRCA1gene mutation (2015) (0)
- An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (0)
- [Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]. (1998) (0)
- Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view (2023) (0)
- Comparative Genomic Hybridization (CGH) analysis of lung cancer in Israel: Comparison of smokers and non-smokers (2000) (0)
- Abstract 39: Platelet Reactivity to Prostaglandin E2 is a Novel Modifiable Risk Factor for St-Elevation Myocardial Infarction (2016) (0)
- Abstract P5-08-10: Surveillance for BRCA1/2 mutation carriers - Is "early detection" really early enough? (2020) (0)
- BRCA1 Mutations in Women With Ovarian Cancer-Reply (1997) (0)
- Risk-reducing salpingo-oophorectomy and breast cancer incidence among BRCA-mutation carriers. (2021) (0)
- Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. (2022) (0)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
- Variations in Practice and Geographic Disparities Between Dedicated Multidisciplinary Clinics for BRCA1/BRCA2 Mutation Carriers in Israel. (2023) (0)
- Stage at breast cancer diagnosis is more advanced in BRCA1 carriers but not in BRCA2 carriers (2007) (0)
- The occurrence and origin of the 185delAG BRCA1 mutation in non-Ashkenazi Jews (1997) (0)
- Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study (2015) (0)
- Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers (2022) (0)
- Overall survival and clinical characteristics of BRCA germline/somatic cholangiocarcinoma (CCA). (2016) (0)
- Germline CDKN1B variant type and site are associated with phenotype in MEN4. (2022) (0)
- Abstract PD6-4: Risk of radiation induced secondary malignancies in gBRCA carriers following breast cancer therapy (2020) (0)
- Title Interplay between BRCA 1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer (2012) (0)
- The I1307K APC mutation in Ashkenazi and non-Ashkenazi Jews: population based study and allelic pattern analysis (1999) (0)
- Secondary cancer after meningioma diagnosis: an Israeli national study (2021) (0)
- Impact of ethnicity on mutations of pancreatic adenocarcinoma in Brazilian patients (2016) (0)
- Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
- Subfertility, use of fertility treatments and BRCA mutation status and the risk of ovarian cancer (2022) (0)
- Correction to: Overlapping genetic architecture between Parkinson disease and melanoma (2020) (0)
- DNA Base-Excision Repair Genes OGG1 and NTH1 in Brazilian Lung Cancer Patients (2015) (0)
- Genet ics Analysis of Polymorphic Patterns in Candidate Genes in Israeli Patients with Prostate Cancer (2003) (0)
- ociation of the Variants CASP 8 D 302 H and CASP 10 0 I with Breast and Ovarian Cancer Risk in B & P A 1 and BRCA 2 Mutation Carriers (2010) (0)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
- 3.051 POLYMORPHISMS IN THE SLC6A3 GENE ENCODING FOR THE DOPAMINE TRANSPORTER ARE ASSOCIATED WITH LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE (2012) (0)
- Cutaneous malignant melanoma and Parkinson ' s disease : common pathways ? Running head : Parkinson ' s disease and malignant melanoma (2016) (0)
- Response to van Steensel and Frank (2006) (0)
- Age at diagnosis of cancer in 185delAG BRCA1 mutation carriers of diverse ethnicities: tentative evidence for modifier factors (2020) (0)
- Functional variant of the tumor suppressor klotho: a novel risk modifier for breast cancer among BRCA1/2 carriers. (2009) (0)
- The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients (2018) (0)
- A composite genomic profile of lung cancer in smokers and nonsmokers (2001) (0)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
- Elevated Hepatocyte Growth Factor is Associated With Worse Prognosis in Cardiac Amyloidosis (2015) (0)
- PIII‐8 (2006) (0)
- A neutral polymorphism (c1088C>T) in the estrogen receptor detected by DGGE Communicated by: Mark H. Paalman Online Citation: Human Mutation, Mutation and Polymorphism Report #58 (1999) Online http://journals.wiley.com/1059-7794/pdf/mutation/mpr58.pdf Acknowledgments: This work was performed in part (1999) (0)
- Abstract 4067: Cell phone use is associated with an inflammatory cytokine profile of parotid gland saliva (2016) (0)
- ELEVATED HEPATOCYTE GROWTH FACTOR IS A NOVEL SPECIFIC MARKER OF CARDIAC AMYLOIDOSIS (2015) (0)
- Endothelin-1 Is Independently Associated with the Annual Risk of Heart Failure Hospitalization (2014) (0)
- Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (2018) (0)
- Local Recurrence in BRCA1/2 Carriers - Is it so Common? (2008) (0)
- Assessing the impact of multiple comorbidities on fatal outcome in young COVID-19 (2021) (0)
- A neutral polymorphism (c1088C>T) in the estrogen receptor detected by DGGE (1999) (0)
- Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (2019) (0)
- 814 Men genotyped for BRCA1/2 mutations: how does it affect them? (2010) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanoma. (2009) (0)
- MC1R gene mutations in Jewish malignant melanoma patients (2006) (0)
- Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (0)
- Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (2012) (0)
- Shared heritability and functional enrichment across six solid cancers (2019) (0)
- The mutation spectrum in HNPCC-suspected patients in Israel: Implications for genetic testing (2001) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers (2018) (0)
- Divergence of mutational signatures in association with breast cancer subtype (2022) (0)
- Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2 (2022) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Ethnicity And Systemic Effects Of Dexmedetomidine, A Specific Adrenergic α: Piii-8-receptor Agonist: Piii-8 (2006) (0)
- Molecular Mechanisms in Parathyroid Tumorigenesis (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Eitan Friedman?
Eitan Friedman is affiliated with the following schools:
